Chronic low back pain (cLBP) is the most common pain condition diagnosed in patients 65 years or older in the United States. While new interventions are being developed, they often cost more, require additional diagnostic tests, and increase visits to health care providers (HCP). Older...
Asthma and allergies are very common health problems. Cells in the blood that are called “inflammatory cells” are involved in the development of asthma and/or allergies, but we do not know exactly how these cells are involved in asthma and/or allergies. In this research study, we...
The Bioanalytical Chemistry for Medicine and the Environment (BCME) Research Team at the University of Washington is currently recruiting study volunteers across the U.S. for a paid COVID-19 research. This study investigates early immune responses to COVID-19 right after infection, before symptoms develop, and follows...
This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. This study will enroll adults who have recently tested positive for SARS-COV-2 and have experienced at least one related mild or moderate symptom. Patients between the ages of 18-59...
People with multiple sclerosis (MS) often have problems with fatigue. For some people, fatigue is their most debilitating symptom of MS. Yet, many of the available treatments provide inadequate relief for fatigue. Past research has found that training in self-hypnosis is linked to reduced fatigue...
Cannabis use disorder (CUD) is a significant and expanding health problem, and no FDA approved treatments are currently available. Persons with posttraumatic stress disorder (PTSD) may use cannabis to help control symptoms. Relief from PTSD insomnia, nightmares, anxiety, and preoccupying thoughts have been reported as...
To evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score To assess the safety and tolerability of troriluzole, relative to placebo,...
To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...
To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...
To assess the effect of donanemab versus placebo on clinical progression in participants with early symptomatic AD with demonstrated presence of tau pathology To assess the effect of donanemab versus placebo on clinical progression of participants with early symptomatic AD To assess the effect of donanemab versus...
